Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025
Bausch Health Companies Inc. (NYSE/TSX: BHC) has scheduled the release of its fourth quarter and full year 2024 financial results for Wednesday, February 19, 2025, after market close. The company will host a conference call and live webcast at 5:00 p.m. U.S. EST on the same day to discuss the results and provide a business update.
Interested parties can access all materials through the Investor Relations section of Bausch Health's website. A replay of the conference call will be made available on the investor relations website. To participate in the live Q&A session, participants must register in advance through the provided link.
Bausch Health Companies Inc. (NYSE/TSX: BHC) ha programmato il rilascio dei suoi risultati finanziari per il quarto trimestre e per l'intero anno 2024 per mercoledì 19 febbraio 2025, dopo la chiusura del mercato. L'azienda ospiterà una chiamata conferenza e una trasmissione in diretta alle 17:00 EST degli Stati Uniti lo stesso giorno per discutere i risultati e fornire un aggiornamento aziendale.
Le parti interessate possono accedere a tutti i materiali attraverso la sezione Relazioni con gli Investitori del sito web di Bausch Health. Una registrazione della chiamata conferenza sarà resa disponibile sul sito delle relazioni con gli investitori. Per partecipare alla sessione di domande e risposte dal vivo, i partecipanti devono registrarsi in anticipo tramite il link fornito.
Bausch Health Companies Inc. (NYSE/TSX: BHC) ha programado la publicación de sus resultados financieros del cuarto trimestre y del año completo 2024 para el miércoles 19 de febrero de 2025, después del cierre del mercado. La compañía llevará a cabo una llamada de conferencia y una transmisión en vivo a las 5:00 p.m. EST de EE. UU. el mismo día para discutir los resultados y proporcionar una actualización del negocio.
Las partes interesadas pueden acceder a todo el material a través de la sección de Relaciones con Inversores en el sitio web de Bausch Health. Se pondrá a disposición una grabación de la llamada de conferencia en el sitio web de relaciones con inversores. Para participar en la sesión de preguntas y respuestas en vivo, los participantes deben registrarse con anticipación a través del enlace proporcionado.
Bausch Health Companies Inc. (NYSE/TSX: BHC)는 2024년 4분기 및 전체 연도 재무 결과 발표를 2025년 2월 19일 수요일 시장 종료 후에 예정하고 있습니다. 회사는 같은 날 오후 5시 미국 동부 표준시(EST)에 결과를 논의하고 사업 업데이트를 제공하기 위해 컨퍼런스 콜 및 라이브 웹캐스트를 주최할 예정입니다.
관심 있는 당사자는 Bausch Health 웹사이트의 투자자 관계 섹션을 통해 모든 자료에 접근할 수 있습니다. 컨퍼런스 콜의 재생은 투자자 관계 웹사이트에서 제공될 것입니다. 라이브 Q&A 세션에 참여하기 위해서는 참여자들이 제공된 링크를 통해 사전 등록해야 합니다.
Bausch Health Companies Inc. (NYSE/TSX: BHC) a prévu la publication de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le mercredi 19 février 2025, après la fermeture du marché. L'entreprise organisera une télé conférence et un webinaire en direct à 17h00, heure de l'Est des États-Unis, le même jour pour discuter des résultats et fournir une mise à jour sur les activités.
Les parties intéressées peuvent accéder à tous les documents via la section Relations Investisseurs du site Web de Bausch Health. Un enregistrement de la télé conférence sera disponible sur le site des relations investisseurs. Pour participer à la session de questions-réponses en direct, les participants doivent s'inscrire à l'avance via le lien fourni.
Bausch Health Companies Inc. (NYSE/TSX: BHC) hat die Veröffentlichung seiner Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 für Mittwoch, den 19. Februar 2025, nach Börsenschluss angesetzt. Das Unternehmen wird am selben Tag um 17:00 Uhr U.S. EST eine Telefonkonferenz und einen Live-Stream abhalten, um die Ergebnisse zu besprechen und ein Update zur Geschäftslage zu geben.
Interessierte Parteien können alle Materialien über den Bereich Investorenbeziehungen auf der Website von Bausch Health abrufen. Eine Wiederholung der Telefonkonferenz wird auf der Website der Investorenbeziehungen zur Verfügung gestellt. Um an der Live-Q&A-Sitzung teilzunehmen, müssen sich die Teilnehmer im Voraus über den zur Verfügung gestellten Link registrieren.
- None.
- None.
LAVAL, QC / ACCESS Newswire / January 23, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release fourth quarter and full year 2024 financial results after market close on Wednesday, February 19, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.
Conference Call Details
Date: | Wednesday, February 19, 2025 |
Time: | 5:00 p.m. U.S. EST |
Webcast: |
A replay of the conference call will be available on the investor relations website.
To participate in the live Q&A session, please register using this link to receive an email confirming your registration.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.
###
Investor Contact:
Garen Sarafian
ir@bauschhealth.com
(877) 281-6642 (toll-free)
Media Contact:
Katie Savastano
corporate.communications@bauschhealth.com
(908) 541-3785
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
FAQ
When will Bausch Health (BHC) release Q4 and full year 2024 earnings?
What time is Bausch Health's (BHC) Q4 2024 earnings call?
How can I access Bausch Health's (BHC) Q4 2024 earnings materials?
How can investors participate in Bausch Health's (BHC) Q4 2024 earnings Q&A session?
